Literature DB >> 9466568

Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.

F Marra1, R DeFranco, C Grappone, S Milani, S Pastacaldi, M Pinzani, R G Romanelli, G Laffi, P Gentilini.   

Abstract

Monocyte chemotactic protein (MCP)-1 is a chemoattractant and activator for circulating monocytes and T lymphocytes. We investigated MCP-1 protein and gene expression during chronic liver disease at different stages, using immunohistochemistry and in situ hybridization, respectively. In normal liver, a modest expression of MCP-1 was confined to few peri-sinusoidal cells and to bile duct epithelial cells. During chronic hepatitis, MCP-1 immunostaining and gene expression were evident in the inflammatory infiltrate of the portal tract. In tissue from patients with active cirrhosis, MCP-1 expression was clearly up-regulated and was present in the portal tract, in the epithelial cells of regenerating bile ducts, and in the active septa surrounding regenerating nodules. A combination of in situ hybridization for MCP-1 and immunohistochemistry showed that activated stellate cells and monocyte/macrophages contribute to MCP-1 expression in vivo together with bile duct epithelial cells. Comparison of serial sections of liver biopsies from patients with various degrees of necro-inflammatory activity showed that infiltration of the portal tracts with monocytes/macrophages is directly correlated with the expression of MCP-1. These data expand previous in vitro studies showing that secretion of MCP-1 may contribute to the formation and maintenance of the inflammatory infiltrate observed during chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466568      PMCID: PMC1857964     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.

Authors:  B J Rollins; T Yoshimura; E J Leonard; J S Pober
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

2.  Identification of monocyte chemotactic activity produced by malignant cells.

Authors:  D T Graves; Y L Jiang; M J Williamson; A J Valente
Journal:  Science       Date:  1989-09-29       Impact factor: 47.728

3.  Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Authors:  S Ylä-Herttuala; B A Lipton; M E Rosenfeld; T Särkioja; T Yoshimura; E J Leonard; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE.

Authors:  T Yoshimura; N Yuhki; S K Moore; E Appella; M I Lerman; E J Leonard
Journal:  FEBS Lett       Date:  1989-02-27       Impact factor: 4.124

5.  Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor.

Authors:  C G Larsen; C O Zachariae; J J Oppenheim; K Matsushima
Journal:  Biochem Biophys Res Commun       Date:  1989-05-15       Impact factor: 3.575

6.  Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors.

Authors:  M Pinzani; H E Abboud; L Gesualdo; S L Abboud
Journal:  Am J Physiol       Date:  1992-04

7.  Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis.

Authors:  H N Antoniades; J Neville-Golden; T Galanopoulos; R L Kradin; A J Valente; D T Graves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Expression of monocyte chemotactic protein-1 in human melanoma in vivo.

Authors:  D T Graves; R Barnhill; T Galanopoulos; H N Antoniades
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  A quantitative ultrastructural analysis of the leukocytes in contact with hepatocytes in chronic active hepatitis, with a cytochemical detection of mononuclear phagocytes.

Authors:  D Bernuau; E Rogier; G Feldmann
Journal:  Am J Pathol       Date:  1982-12       Impact factor: 4.307

10.  RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis.

Authors:  C M Lloyd; A W Minto; M E Dorf; A Proudfoot; T N Wells; D J Salant; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  95 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

2.  Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes.

Authors:  Xiao Zhang; Guangli Du; Ying Xu; Xuewei Li; Weiwei Fan; Jiamei Chen; Cheng Liu; Gaofeng Chen; Chenghai Liu; Mark A Zern; Yongping Mu; Ping Liu
Journal:  Lab Invest       Date:  2015-12-21       Impact factor: 5.662

3.  Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.

Authors:  Anna Baghdasaryan; Thierry Claudel; Astrid Kosters; Judith Gumhold; Dagmar Silbert; Andrea Thüringer; Katharina Leski; Peter Fickert; Saul J Karpen; Michael Trauner
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

Review 4.  Renaming cytokines: MCP-1, major chemokine in pancreatitis.

Authors:  F Marra
Journal:  Gut       Date:  2005-06-15       Impact factor: 23.059

5.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

Authors:  Ramon Bataller; Robert F Schwabe; Youkyung H Choi; Liu Yang; Yong Han Paik; Jeffrey Lindquist; Ting Qian; Robert Schoonhoven; Curt H Hagedorn; John J Lemasters; David A Brenner
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

6.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

7.  Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.

Authors:  James P Luyendyk; Bradley P Sullivan; Grace L Guo; Ruipeng Wang
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  CCR1 and CCR5 promote hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele De Minicis; Geum-Youn Gwak; Johannes Kluwe; Sayaka Inokuchi; Christina A Bursill; Josep M Llovet; David A Brenner; Robert F Schwabe
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

9.  IL-6 downregulates transcription of NTPDase2 via specific promoter elements.

Authors:  Jin Yu; Elise G Lavoie; Nina Sheung; Jacques J Tremblay; Jean Sévigny; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-17       Impact factor: 4.052

10.  CCR2 promotes hepatic fibrosis in mice.

Authors:  Ekihiro Seki; Samuele de Minicis; Sayaka Inokuchi; Kojiro Taura; Katsumi Miyai; Nico van Rooijen; Robert F Schwabe; David A Brenner
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.